| Application number | Title of the application | Filing Date | Status |
|---|
| 10/048413 | Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorder | Mar 28, 2002 | Abandoned |
Array
(
[id] => 6177726
[patent_doc_number] => 20020156016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Control of cell growth by altering cell membrane potentials'
[patent_app_type] => new
[patent_app_number] => 10/114009
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8407
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20020156016.pdf
[firstpage_image] =>[orig_patent_app_number] => 10114009
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/114009 | Control of cell growth by altering cell membrane potentials | Mar 27, 2002 | Abandoned |
Array
(
[id] => 6716451
[patent_doc_number] => 20030027799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Methods of treating cancer using a combination of drugs'
[patent_app_type] => new
[patent_app_number] => 10/107795
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5883
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027799.pdf
[firstpage_image] =>[orig_patent_app_number] => 10107795
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/107795 | Methods of treating cancer using a combination of drugs | Mar 27, 2002 | Abandoned |
Array
(
[id] => 6761975
[patent_doc_number] => 20030125337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Inhibitors of multidrug transporters'
[patent_app_type] => new
[patent_app_number] => 10/106839
[patent_app_country] => US
[patent_app_date] => 2002-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22077
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125337.pdf
[firstpage_image] =>[orig_patent_app_number] => 10106839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/106839 | Inhibitors of multidrug transporters | Mar 25, 2002 | Abandoned |
Array
(
[id] => 6017260
[patent_doc_number] => 20020103250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Method of treatment or prophylaxis'
[patent_app_type] => new
[patent_app_number] => 10/105118
[patent_app_country] => US
[patent_app_date] => 2002-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2179
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103250.pdf
[firstpage_image] =>[orig_patent_app_number] => 10105118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/105118 | Method of treatment or prophylaxis | Mar 21, 2002 | Abandoned |
Array
(
[id] => 6830463
[patent_doc_number] => 20030181521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Use of vegetable butter-based cetyl myristoleate for treating osteoarthritis and other musculoskeletal disease conditions and injuries'
[patent_app_type] => new
[patent_app_number] => 10/103447
[patent_app_country] => US
[patent_app_date] => 2002-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2100
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181521.pdf
[firstpage_image] =>[orig_patent_app_number] => 10103447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/103447 | Use of vegetable butter-based cetyl myristoleate for treating osteoarthritis and other musculoskeletal disease conditions and injuries | Mar 20, 2002 | Issued |
| 10/088629 | Treating allergic and inflammatory conditions | Mar 18, 2002 | Abandoned |
Array
(
[id] => 5845441
[patent_doc_number] => 20020132840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Medicament'
[patent_app_type] => new
[patent_app_number] => 10/100248
[patent_app_country] => US
[patent_app_date] => 2002-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11749
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132840.pdf
[firstpage_image] =>[orig_patent_app_number] => 10100248
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/100248 | Medicament | Mar 14, 2002 | Abandoned |
| 10/018545 | METHOD OF ADMINISTERING AN IMIDAZOLE DERIVATIVE TO OBTAIN ANALGESIA | Mar 7, 2002 | Abandoned |
| 09/979509 | Mag expression promoters | Mar 4, 2002 | Abandoned |
Array
(
[id] => 7631272
[patent_doc_number] => 06635660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-10-21
[patent_title] => 'Methods of inhibiting sphincter incontinence'
[patent_app_type] => B2
[patent_app_number] => 10/087248
[patent_app_country] => US
[patent_app_date] => 2002-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9098
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635660.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087248
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087248 | Methods of inhibiting sphincter incontinence | Feb 28, 2002 | Issued |
Array
(
[id] => 6870648
[patent_doc_number] => 20030083338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Compositions and methods for management of serotonin-mediated disorders'
[patent_app_type] => new
[patent_app_number] => 10/087596
[patent_app_country] => US
[patent_app_date] => 2002-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14431
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083338.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087596
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087596 | Compositions and methods for management of serotonin-mediated disorders | Feb 28, 2002 | Abandoned |
Array
(
[id] => 1073804
[patent_doc_number] => 06838469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-04
[patent_title] => 'Pharmaceutical composition that exhibits reduced side-effects comprising O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime and a pyrimidine derivative with known antitumor activity'
[patent_app_type] => utility
[patent_app_number] => 10/084095
[patent_app_country] => US
[patent_app_date] => 2002-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5841
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838469.pdf
[firstpage_image] =>[orig_patent_app_number] => 10084095
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/084095 | Pharmaceutical composition that exhibits reduced side-effects comprising O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime and a pyrimidine derivative with known antitumor activity | Feb 27, 2002 | Issued |
Array
(
[id] => 6261713
[patent_doc_number] => 20020187919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Methods for preventing pressure induced apoptotic neural cell death'
[patent_app_type] => new
[patent_app_number] => 10/084604
[patent_app_country] => US
[patent_app_date] => 2002-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2807
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20020187919.pdf
[firstpage_image] =>[orig_patent_app_number] => 10084604
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/084604 | Methods for preventing pressure induced apoptotic neural cell death | Feb 26, 2002 | Abandoned |
Array
(
[id] => 1292613
[patent_doc_number] => RE038253
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2003-09-16
[patent_title] => 'Composition for contraception'
[patent_app_type] => E1
[patent_app_number] => 10/080617
[patent_app_country] => US
[patent_app_date] => 2002-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2714
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038253.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080617 | Composition for contraception | Feb 24, 2002 | Issued |
Array
(
[id] => 6847417
[patent_doc_number] => 20030166584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Cytochrome P450 3A inhibitors and enhancers'
[patent_app_type] => new
[patent_app_number] => 10/080043
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5142
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166584.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080043
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080043 | Cytochrome P450 3A inhibitors and enhancers | Feb 21, 2002 | Issued |
Array
(
[id] => 1279064
[patent_doc_number] => 06646005
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-11
[patent_title] => 'Method of treating hair loss using sulfonyl thyromimetic compounds'
[patent_app_type] => B1
[patent_app_number] => 09/980351
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7429
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/646/06646005.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980351
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980351 | Method of treating hair loss using sulfonyl thyromimetic compounds | Feb 20, 2002 | Issued |
| 09/936772 | Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin | Feb 20, 2002 | Abandoned |
Array
(
[id] => 687010
[patent_doc_number] => 07078436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-18
[patent_title] => 'Carbamate compounds for use in preventing or treating anxiety disorders'
[patent_app_type] => utility
[patent_app_number] => 10/081713
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5282
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/078/07078436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081713
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081713 | Carbamate compounds for use in preventing or treating anxiety disorders | Feb 20, 2002 | Issued |
Array
(
[id] => 6569527
[patent_doc_number] => 20020165273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Carbamate compounds for use in preventing or treating neurodegenerative disorders'
[patent_app_type] => new
[patent_app_number] => 10/081764
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6084
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081764
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081764 | Carbamate compounds for use in preventing or treating neurodegenerative disorders | Feb 20, 2002 | Abandoned |
